Skip to main content

Table 4 Serum Hp polymorphism in the patients and normal controls

From: Serum proteomic profiling and haptoglobin polymorphisms in patients with GVHD after allogeneic hematopoietic cell transplantation

  

Hp phenotype

Patients

 

1-1

2-1

2-2

Chronic GVHD

n = 16

2(12.5%)

7(43.8%)

7(43.8%)

no GVHD

n = 9

1(11.1%)

8(88.9%)

0

Normal Donor

n = 16

1(6.3%)

12(75.0%)

3(18.7%)